Intra Cellular Therapies | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
ALKERMES USD 4.65M 1.35M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Cytokinetics USD 22.59M 296K 2024-12
Gilead Sciences USD 248M 10M 2024-12
Halozyme Therapeutics USD 4.54M 16K 2024-12
Intra Cellular Therapies 5.97M 966K 2023-12
J&J USD 137M 56M 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Prothena 0 0 2024-06
RedHill Biopharma 89.8K 31.69M 2024-06
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12



Intra Cellular Therapies Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.